12. Intangible assets

Intangible assets 2019





EUR 1,000
Goodwill Product development costs Other intangible assets Total






Acquisition cost 1 Jan 17,528 14,406 6,952 38,886
Exchange differences

-75 -75
Additions
2,947
2,947
Disposals

-755 -755
Acquisition cost 31 Dec 17,528 17,353 6,122 41,003





Accumulated amortisations and impairment losses 1 Jan -17,528 -14,406 -6,753 -38,687
Exchange differences

849 849
Accumulated amortisations on disposals



Impairment loss on goodwill



Amortisation during period

-168 -168
Accumulated amortisations and impairment losses 31 Dec -17,528 -14,406 -6,072 -38,006






Book value 31 Dec 2019
2,947 50 2,997






Product development costs and impairment testing




Capitalized product development costs inlude EUR 2,947 (0) thousand such products that are not yet in commercial use, and therefore not amortized. These intangibles in progress are tested for impairment annually, and they are allocated to operating segments as follows: MEA & APAC EUR 2,071 (0) thousand and Americas & Europe EUR 876 (0) thousand. Based on the impairment tests performed, there is no need to recognize an impairment loss on intangibles in progress. Research and development costs recorded in the income statement are presented in note 8.












Intangible assets 2018





EUR 1,000
Goodwill Product development costs Other intangible assets Total






Acquisition cost 1 Jan 17,528 14,406 7,134 39,068
Exchange differences

-147 -147
Additions



Disposals

-34 -34
Acquisition cost 31 Dec 17,528 14,406 6,952 38,886





Accumulated amortisations and impairment losses 1 Jan -17,528 -14,406 -6,871 -38,805
Exchange differences

186 186





Accumulated amortisations on disposals



Amortisation during period

-68 -68
Accumulated amortisations and impairment losses 31 Dec -17,528 -14,406 -6,753 -38,687






Book value 31 Dec 2018

199 199